After a validation study aimed to evaluate gene expression signature in three genes (PCA3, ERG and SPDEF) involved in PCa progression, they focused on n = 255 not biopsied PCa patients with PSA level >2. The gene discussed is ERG; the disease is posterior cortical atrophy.